BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33039145)

  • 21. Extracorporeal photopheresis to attenuate decline in lung function due to refractory obstructive allograft dysfunction.
    ; Hage CA; Klesney-Tait J; Wille K; Arcasoy S; Yung G; Hertz M; Chan KM; Morrell M; Goldberg H; Vedantham S; Derfler MC; Commean P; Berman K; Spitznagel E; Atkinson J; Despotis G
    Transfus Med; 2021 Aug; 31(4):292-302. PubMed ID: 33955079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of a post-transplant chronic lung allograft dysfunction classification system.
    Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
    J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome After Lung Transplantation.
    Pecoraro Y; Carillo C; Diso D; Mantovani S; Cimino G; De Giacomo T; Troiani P; Shafii M; Gherzi L; Amore D; Rendina EA; Venuta F; Anile M
    Transplant Proc; 2017 May; 49(4):695-698. PubMed ID: 28457374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation.
    Morrell MR; Despotis GJ; Lublin DM; Patterson GA; Trulock EP; Hachem RR
    J Heart Lung Transplant; 2010 Apr; 29(4):424-31. PubMed ID: 19853479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of extracorporeal photopheresis on lung function decline for severe bronchiolitis obliterans syndrome following allogeneic stem cell transplantation.
    Brownback KR; Simpson SQ; Pitts LR; Polineni D; McGuirk JP; Ganguly S; Aljitawi OS; Lin TL; Singh A; Abhyankar S
    J Clin Apher; 2016 Aug; 31(4):347-52. PubMed ID: 26031713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
    Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
    J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung Density Analysis Using Quantitative Chest CT for Early Prediction of Chronic Lung Allograft Dysfunction.
    Horie M; Levy L; Houbois C; Salazar P; Saito T; Pakkal M; OʼBrien C; Sajja S; Brock K; Yasufuku K; Keshavjee S; Paul N; Martinu T
    Transplantation; 2019 Dec; 103(12):2645-2653. PubMed ID: 31343572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Montelukast in chronic lung allograft dysfunction after lung transplantation.
    Vos R; Eynde RV; Ruttens D; Verleden SE; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck DE; Verleden GM;
    J Heart Lung Transplant; 2019 May; 38(5):516-527. PubMed ID: 30638839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
    Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
    J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Azithromycin and early allograft function after lung transplantation: A randomized, controlled trial.
    Van Herck A; Frick AE; Schaevers V; Vranckx A; Verbeken EK; Vanaudenaerde BM; Sacreas A; Heigl T; Neyrinck AP; Van Raemdonck D; Dupont LJ; Yserbyt J; Verleden SE; Verleden GM; Vos R
    J Heart Lung Transplant; 2019 Mar; 38(3):252-259. PubMed ID: 30686699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exosomal-miRNas expression and growth factors released by mononuclear cells of CLAD patients in response to extracorporeal photopheresis.
    Bozzini S; Bozza E; Bagnera C; Del Fante C; Barone E; De Vitis S; De Amici M; Testa G; Croce S; Valsecchi C; Avanzini MA; Cacciatore R; Mortellaro C; Viarengo G; Perotti C; Meloni F
    J Transl Med; 2024 Mar; 22(1):276. PubMed ID: 38486224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracorporeal photopheresis in the treatment of cardiac allograft rejection: A single-centre experience.
    Teszak T; Assabiny A; Kiraly A; Tarjanyi Z; Parazs N; Szakal-Toth Z; Hartyanszky I; Szabolcs Z; Racz K; Reti M; Merkely B; Sax B
    Transpl Immunol; 2023 Aug; 79():101853. PubMed ID: 37196865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracorporeal photopheresis: a useful therapy for patients with steroid-refractory acute graft-versus-host disease but not for the prevention of the chronic form.
    Rubegni P; Feci L; Poggiali S; Marotta G; D'Ascenzo G; Murdaca F; Fimiani M
    Br J Dermatol; 2013 Aug; 169(2):450-7. PubMed ID: 23534380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of CT-SCAN score and volume measures to early identify restrictive allograft syndrome in single lung transplant recipients.
    Philippot Q; Debray MP; Bun R; Frija-Masson J; Bunel V; Morer L; Roux A; Picard C; Jebrak G; Dauriat G; Castier Y; Cazes A; Mal H; Taupin JL; Couffignal C; Brugière O
    J Heart Lung Transplant; 2020 Feb; 39(2):125-133. PubMed ID: 31836403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal one-year post-lung transplant spirometry is a significant predictor of increased mortality and chronic lung allograft dysfunction.
    Paraskeva MA; Borg BM; Paul E; Fuller J; Westall GP; Snell GI
    J Heart Lung Transplant; 2021 Dec; 40(12):1649-1657. PubMed ID: 34548197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT.
    Lucid CE; Savani BN; Engelhardt BG; Shah P; Clifton C; Greenhut SL; Vaughan LA; Kassim A; Schuening F; Jagasia M
    Bone Marrow Transplant; 2011 Mar; 46(3):426-9. PubMed ID: 20581885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study.
    Sakellari I; Gavriilaki E; Batsis I; Mallouri D; Panteliadou AK; Lazaridou A; Vardi A; Constantinou V; Yannaki E; Papalexandri A; Kaloyannidis P; Smias C; Anagnostopoulos A
    J Clin Apher; 2018 Dec; 33(6):654-660. PubMed ID: 30394564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracorporeal photopheresis in the treatment of acute graft-versus-host disease: a single-center experience.
    Niittyvuopio R; Juvonen E; Heiskanen J; Lindström V; Nihtinen A; Sahlstedt L; Volin L
    Transfusion; 2018 Aug; 58(8):1973-1979. PubMed ID: 29707788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of gram negative bacteria airway recolonization on the occurrence of chronic lung allograft dysfunction after lung transplantation in a population of cystic fibrosis patients.
    Orfanos S; Gomez C; Baron S; Akkisetty R; Dufeu N; Coltey B; Thomas PA; Rolain JM; Reynaud-Gaubert M
    BMC Microbiol; 2018 Aug; 18(1):88. PubMed ID: 30126365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of extracorporeal photopheresis for allograft rejection in liver transplant recipients.
    Urbani L; Mazzoni A; Catalano G; De Simone P; Vanacore R; Pardi C; Bortoli M; Biancofiore G; Campani D; Perrone V; Mosca F; Scatena F; Filipponi F
    Transplant Proc; 2004 Dec; 36(10):3068-70. PubMed ID: 15686696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.